Fayez Sarofim & Co’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-626
| Closed | -$201K | – | 288 |
|
2024
Q2 | $201K | Sell |
626
-190
| -23% | -$61K | ﹤0.01% | 277 |
|
2024
Q1 | $272K | Hold |
816
| – | – | ﹤0.01% | 261 |
|
2023
Q4 | $250K | Sell |
816
-287
| -26% | -$87.9K | ﹤0.01% | 266 |
|
2023
Q3 | $271K | Hold |
1,103
| – | – | ﹤0.01% | 260 |
|
2023
Q2 | $335K | Hold |
1,103
| – | – | ﹤0.01% | 230 |
|
2023
Q1 | $291K | Hold |
1,103
| – | – | ﹤0.01% | 249 |
|
2022
Q4 | $265K | Hold |
1,103
| – | – | ﹤0.01% | 259 |
|
2022
Q3 | $203K | Buy |
+1,103
| New | +$203K | ﹤0.01% | 272 |
|
2022
Q2 | – | Sell |
-1,103
| Closed | -$276K | – | 302 |
|
2022
Q1 | $276K | Hold |
1,103
| – | – | ﹤0.01% | 293 |
|
2021
Q4 | $283K | Hold |
1,103
| – | – | ﹤0.01% | 303 |
|
2021
Q3 | $268K | Hold |
1,103
| – | – | ﹤0.01% | 285 |
|
2021
Q2 | $228K | Hold |
1,103
| – | – | ﹤0.01% | 305 |
|
2021
Q1 | $208K | Buy |
+1,103
| New | +$208K | ﹤0.01% | 284 |
|